ArticleCardiovascular diabetology2025

Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease.

Narainrit Karuna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.